New Key Statistics Module, Z-Score and F-Score
OTCPK:IVBXF Key Ratios
| Market Cap $ M | 8,064.98 |
| Enterprise Value $ M | 7,362.73 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 323.33 |
| Price/Book | 4.80 |
| Price/Sales | 7.82 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1,035.00 |
| EPS (TTM) $ | -0.11 |
| Beneish M-Score | -2.26 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 40.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -44.16 |
| EV-to-EBITDA | -65.96 |
| PEG | -- |
| Shares Outstanding M | 1,628.41 |
| Net Margin (%) | -17.25 |
| Operating Margin % | -10.63 |
| Pre-tax Margin (%) | -17.24 |
| Quick Ratio | 2.51 |
| Current Ratio | 2.68 |
| ROA % (ttm) | -6.54 |
| ROE % (ttm) | -10.76 |
| ROIC % (ttm) | -7.41 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.69 |
IVBXF Number of Guru Trades
IVBXF Volume of Guru Trades
Gurus Latest Trades with OTCPK:IVBXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:IVBXF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Innovent Biologics Inc Insider Transactions
No Available Data
News about OTCPK:IVBXF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers